Search Results

You are looking at 1 - 10 of 2,367 items for :

  • "treatment" x
Clear All
Full access

Eric T. Wong and Steven Brem

: 649 . 5. Mayer RJ . Two steps forward in the treatment of colorectal cancer . New Engl J Med 2004 ; 350 : 2406 – 2408 . 6. Shweiki D Itin A Soffer D . Vascular endothelial growth factor induced by hypoxia may mediate hypoxia

Full access

Lindsey Robert Baden, William Bensinger, Michael Angarone, Corey Casper, Erik R. Dubberke, Alison G. Freifeld, Ramiro Garzon, John N. Greene, John P. Greer, James I. Ito, Judith E. Karp, Daniel R. Kaul, Earl King, Emily Mackler, Kieren A. Marr, Jose G. Montoya, Ashley Morris-Engemann, Peter G. Pappas, Ken Rolston, Brahm Segal, Susan K. Seo, Sankar Swaminathan, Maoko Naganuma and Dorothy A. Shead

). The major categories of immunologic deficits in persons with cancer and the major pathogens to which they are susceptible are characterized. Specific guidelines are provided on the prevention, diagnosis, and treatment of the major common and

Full access

Thomas Prebet and Steven D. Gore

T he treatment of acute myeloid leukemia (AML) in older patients remains challenging. 1 Both disease- and patient-related factors unfavorably influence patient outcome, with a 2-year probability of overall survival of 10% to 15%. 2 Acute

Full access

Harry S. Cooper

1986 ; 91 : 419 – 427 . 8. Bond JH . Polyp guideline: diagnosis, treatment, and surveillance for patients with colorectal polyps. Practice Parameters Committee of the American College of Gastroenterology . Am J Gastroenterol 2000 ; 95

Full access

Saurabh Rajguru and Brad S. Kahl

/print certificate. Release date: September 5, 2014; Expiration date: September 5, 2015 Learning Objectives Upon completion of this activity, participants will be able to: Summarize the current and emerging treatment options for MCL in the frontline

Full access

R. Lor Randall and William Gowski

. Instr Course Lect 1996 ; 45 : 417 – 424 . 4 Marcove RC Stovell PB Huvos AG . The use of cryosurgery in the treatment of low and medium grade chondrosarcoma. A preliminary report . Clin Orthop 1977 ; 122 : 147 – 156 . 5 Reith

Full access

Siew Tzuh Tang, Tsang-Wu Liu, Fur-Hsing Wen, Chiun Hsu, Yi-Heng Chang, Cheng-Shyong Chang, Yung-Chuan Sung, Cheng-I Hsieh, Shou-Yi Chang, Li Ni Liu and Ming-Chu Chiang

Background Eliciting and honoring patients' treatment preferences are recognized as essential to high-quality end-of-life (EOL) care, 1 whereas ignoring patients' preferences is considered a medical error. 2 However, physicians tend to

Full access

Erich M. Sturgis and K. Kian Ang

stagnate survival for those with laryngeal and oral cavity cancer. 2 , 4 Some oncologists believe that the greater use of multimodality chemoradiation in the treatment of oropharyngeal cancer can account for the observed dramatically improved survival

Full access

Matthew P. Banegas, Linda C. Harlan, Bhupinder Mann and K. Robin Yabroff

treated for localized disease, and nearly 30% will be diagnosed with metastatic disease. 2 While surgery remains the primary treatment for localized RCC, 3 treatment options for metastatic RCC have changed markedly in the past decade. Before 2005

Full access

Erin E. Hahn, Michael K. Gould, Corrine E. Munoz-Plaza, Janet S. Lee, Carla Parry and Ernest Shen

increase due to advances in cancer detection and treatment, as well as the aging of the population. 2 , 3 This increasing patient population, with a mean age at diagnosis of 69 years, frequently presents with multiple comorbid conditions and complex care